Language

Medicine shortages: Belgium · Page 6

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 6 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 6

Belgium

Litican 50 mg tabl. 20 (20 x 1) UD

Marketing ended · Commercial reasons
Active ingredient: Alizapride

Notice details →
Belgium

Litican 50 mg tabl. 20

Marketing ended · Commercial reasons
Active ingredient: Alizapride

Notice details →
Belgium

Lokelma 10 g (PI Pharma) or. susp. (pwdr.) sachet 30

Nicht verfügbar · Sonstige
Active ingredient: Sodium Zirconium Cyclosilicate

Notice details →
Belgium

Macrogol + Electrolytes AB 13.7 g or. sol. (pwdr.) sachet 30

Marketing ended · Sonstige
Active ingredient: Macrogol,Potassium Chloride,Sodium Hydrogen Carbonate,Sodium Chloride

Notice details →
Belgium

Micropaque Suspension 1 g/ml or./rect. susp. 2 l

Nicht verfügbar · Manufacturing delay
Active ingredient: Barium Sulfate

Notice details →
Belgium

Myrosor 20 mg - 10 mg (PI Pharma) film-coat. tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Ezetimibe ,Rosuvastatin

Notice details →
Belgium

Nifedipine Retard EG 60 mg tabl. prol.-rel. 98

Available again · Not specified
Active ingredient: Nifedipine

Notice details →
Belgium

Olmesartan/HCTZ Krka 40 mg - 25 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Hydrochlorothiazide,Olmesartan Medoxomil

Notice details →
Belgium

Olmetec 20 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil

Notice details →
Belgium

Omeprazol AB 20 mg hard gastro-resist. caps. 56

Marketing ended · Sonstige
Active ingredient: Omeprazole

Notice details →
Belgium

Omic Ocas 0.4 mg (PI Pharma) tabl. prol.-rel. 200

Nicht verfügbar · Sonstige
Active ingredient: Tamsulosin Hydrochloride

Notice details →
Belgium

Omic Ocas 0.4 mg (PI Pharma) tabl. prol.-rel. 90

Nicht verfügbar · Sonstige
Active ingredient: Tamsulosin Hydrochloride

Notice details →
Belgium

Pantoprazol AB 40 mg gastro-resist. tabl. 56

Marketing ended · Sonstige
Active ingredient: Pantoprazole

Notice details →
Belgium

Pradaxa 110 mg coat. gran. sachet 60

Marketing ended · Revocation of the authorisation
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 110 mg hard caps. 60 (60 x 1) UD

Marketing ended · Insufficient demand
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 150 mg coat. gran. sachet 60

Marketing ended · Revocation of the authorisation
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 20 mg coat. gran. sachet 60

Marketing ended · Revocation of the authorisation
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 30 mg coat. gran. sachet 60

Marketing ended · Revocation of the authorisation
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 40 mg coat. gran. sachet 60

Marketing ended · Revocation of the authorisation
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Pradaxa 50 mg coat. gran. sachet 60

Marketing ended · Revocation of the authorisation
Active ingredient: Dabigatran Etexilate

Notice details →
Belgium

Prevenar 13 (Orifarm) inj. susp. i.m. pre-filled syr. 0.5 ml

Marketing ended · Sonstige
Active ingredient: Pneumococcal Polysaccharide Conjugate Vaccine, Adsorbed, 13-Valent

Notice details →
Belgium

Ranomax 400 µg hard caps. prol.-rel. 100

Marketing ended · Sonstige
Active ingredient: Tamsulosin Hydrochloride

Notice details →
Belgium

Relvar Ellipta 92 µg - 22 µg (PI Pharma) inhal. pwdr. (pre-dispens.) 30

Nicht verfügbar · Sonstige
Active ingredient: Fluticasone Furoate,Vilanterol

Notice details →
Belgium

Relvar Ellipta 92 µg - 22 µg (PI Pharma) inhal. pwdr. (pre-dispens.) 90 (3 x 30)

Nicht verfügbar · Sonstige
Active ingredient: Fluticasone Furoate,Vilanterol

Notice details →
Belgium

Rewellfem 10 µg vagin. tabl. 18

Nicht verfügbar · Sonstige
Active ingredient: Estradiol

Notice details →
Belgium

Ryaltris 25 µg/dose - 600 µg/dose (PI Pharma) nas. spray susp. met. pump 29 g (240 doses)

Nicht verfügbar · Sonstige
Active ingredient: Olopatadine ,Mometasone Furoate

Notice details →
Belgium

Saizen 5.83 mg/ml inj. sol. s.c. cartr. 5 x 1.03 ml (6 mg)

Nicht verfügbar · Manufacturing delay
Active ingredient: Somatropin

Notice details →
Belgium

Seroquel XR 50 mg (PI Pharma) tabl. prol.-rel. 30

Nicht verfügbar · Sonstige
Active ingredient: Quetiapine

Notice details →
Belgium

Sertraline EG 50 mg (PI Pharma) film-coat. tabl. 30

Available again · Not specified
Active ingredient: Sertraline Hydrochloride

Notice details →
Belgium

Sertraline EG 50 mg (PI Pharma) film-coat. tabl. 60

Available again · Not specified
Active ingredient: Sertraline Hydrochloride

Notice details →
Belgium

Stugeron 25 mg tabl. 200

Marketing ended · Commercial reasons
Active ingredient: Cinnarizine

Notice details →
Belgium

Tramadol Krka 150 mg tabl. prol.-rel. 100

Nicht verfügbar · Sonstige
Active ingredient: Tramadol Hydrochloride

Notice details →
Belgium

Vimpat 50 mg film-coat. tabl. 56 (56 x 1) UD

Marketing ended · Commercial reasons
Active ingredient: Lacosamide

Notice details →
Belgium

Wilfactin 1 000 IU/10 ml inj. sol. (pwdr. + solv.) i.v. vial 1000 IU + 10 ml

Available again · Not specified
Active ingredient: Human Factor von Willebrand

Notice details →
Belgium

Xyrem 500 mg/ml or. sol. 180 ml

Marketing ended · Commercial reasons
Active ingredient: Sodium Oxybate

Notice details →
Belgium

Yuflyma 40 mg (PI Pharma) inj. sol. s.c. pre-filled pen 6 x 0.4 ml

Nicht verfügbar · Sonstige
Active ingredient: Adalimumab

Notice details →
Belgium

Actosolv 100 000 IU inj./inf. sol. (pwdr.) i.v./i.arter. 100000 IU

Nicht verfügbar · Sonstige
Active ingredient: Urokinase

Notice details →
Belgium

Actosolv 600 000 IU inj./inf. sol. (pwdr.) i.v./i.arter. 600000 IU

Nicht verfügbar · Sonstige
Active ingredient: Urokinase

Notice details →
Belgium

Adenocor 6 mg/2 ml inj. sol. i.v. vial 6 x 2 ml

Available again · Not specified
Active ingredient: Adenosine

Notice details →
Belgium

Amoxicillin/Clavulanic Acid AB 500 mg - 125 mg film-coat. tabl. 16

Available again · Not specified
Active ingredient: Amoxicillin,Clavulanic Acid

Notice details →
Belgium

CoAprovel 150 mg - 12.5 mg film-coat. tabl. 28

Marketing ended · Commercial reasons
Active ingredient: Irbesartan,Hydrochlorothiazide

Notice details →
Belgium

Desorelle 30 150 µg - 30 µg film-coat. tabl. 6 x 21

Nicht verfügbar · Manufacturing delay
Active ingredient: Ethinylestradiol,Desogestrel

Notice details →
Belgium

Doxycycline Sandoz 100 mg tabl. 10

Nicht verfügbar · Increased demand
Active ingredient: Doxycycline Monohydrate

Notice details →
Belgium

Elvanse 30 mg hard caps. 30

Available again · Not specified
Active ingredient: Dexamfetamine

Notice details →
Belgium

Evra 6 mg - 600 µg transderm. patch sachet 9

Available again · Not specified
Active ingredient: Ethinylestradiol,Norelgestromin

Notice details →
Belgium

Gabapentine Teva 100 mg hard caps. 200

Nicht verfügbar · Manufacturing delay
Active ingredient: Gabapentin

Notice details →
Belgium

Ixiaro inj. susp. i.m./s.c. pre-filled syr. 0.5 ml

Available again · Not specified
Active ingredient: Encephalitis Virus, Japanese, Inactivated

Notice details →
Belgium

Lasix 40 mg tabl. 50

Available again · Not specified
Active ingredient: Furosemide

Notice details →
Belgium

Minims Tetracaine Hydrochloride 10 mg/ml eye drops sol. single-dose cont. 20 x 0.5 ml

Nicht verfügbar · Increased demand
Active ingredient: Tetracaine

Notice details →
Belgium

Olmetec Plus 20 mg - 12.5 mg film-coat. tabl. 98

Available again · Not specified
Active ingredient: Olmesartan Medoxomil,Hydrochlorothiazide

Notice details →